Wegovy is available through the NHS for patients meeting specific criteria. To qualify, individuals generally need to have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as diabetes or hypertension. Wegovy is a relatively new option and is prescribed under careful medical supervision.

A non-surgical sleeve refers to procedures that mimic the effects of sleeve gastrectomy but without surgery. One such method is the Endoscopic Sleeve Gastroplasty (ESG), which reduces stomach size using sutures inserted through an endoscope. This approach is less invasive, has a faster recovery time, and is typically used for patients who do not qualify for surgical interventions.

Roux-en-Y Gastric Bypass (RYGB) is a popular form of bariatric surgery that reduces the size of the stomach and reroutes the digestive system. This results in both restriction of food intake and malabsorption, leading to significant weight loss. The surgery is considered highly effective for morbidly obese individuals and also helps improve obesity-related health issues like diabetes, hypertension, and sleep apnea. However, it requires lifelong dietary changes and nutritional supplements to avoid deficiencies.

The "Skinny Pen" refers to a weight-loss medication called liraglutide (brand name Saxenda) that is administered through a daily injection. It works by mimicking a hormone that regulates appetite, helping patients feel fuller for longer. This treatment is often used for individuals who struggle with obesity but are not candidates for surgery or who need additional help in managing their weight post-bariatric surgery. The drug is available by prescription and is used in conjunction with diet and exercise.

Lap band surgery, also known as gastric banding, is a type of weight-loss surgery where a band is placed around the upper part of the stomach to create a small pouch. This restricts food intake, leading to weight loss. In the UK, lap band surgery is available through both private healthcare providers and the NHS. The procedure has become less common compared to other forms of bariatric surgery, such as the RNY or sleeve gastrectomy, due to its lower success rates and higher complication risks.

The "fat jab," also known as Saxenda or liraglutide, is an injectable weight-loss drug that has been approved for use on the NHS in the UK for individuals struggling with obesity. It is intended for use in conjunction with a reduced-calorie diet and increased physical activity. The medication helps control appetite, leading to weight loss. It is typically prescribed to those with a BMI over 30 or individuals with weight-related health problems.

Before-and-after images of gastric sleeve patients highlight not only the weight loss but also the excess skin that may remain, especially in areas like the abdomen. Many patients opt for skin removal surgeries after achieving their weight-loss goals.

Another term for the Roux-en-Y gastric bypass, the Roux bypass is highly regarded for its effectiveness in helping patients lose weight and improve health conditions related to obesity. Named after the French surgeon César Roux, this procedure is a combination of both restrictive and malabsorptive techniques. It requires a lifetime commitment to dietary changes, exercise, and regular follow-up with healthcare professionals.

Sleeve surgery is another term for the gastric sleeve procedure, where most of the stomach is removed to help patients achieve significant weight loss. The procedure is less invasive than other forms of bariatric surgery, like the Roux-en-Y bypass, but still offers dramatic weight-loss results.

A gastric balloon is a non-surgical weight-loss option where a silicone balloon is inserted into the stomach and inflated. It takes up space, helping patients feel fuller sooner and eat less. The balloon is temporary and is removed after 6-12 months, during which patients must follow a strict diet and exercise regimen to ensure lasting weight loss.

Diarrhoea associated with gastritis can occur due to inflammation in the stomach affecting the intestines. This symptom often accompanies nausea, bloating, and abdominal pain. Managing diarrhea involves treating the underlying gastritis, typically with acid-reducing medications and dietary adjustments.

Cancer of the Gastrointestinal Tract (GIT) includes cancers that affect the stomach, intestines, esophagus, colon, liver, and pancreas. Symptoms vary depending on the type of cancer but may include weight loss, blood in the stool, or persistent abdominal pain. Early detection is crucial for improving survival rates, and treatment options range from surgery to chemotherapy and radiation.

A tumor on the abdomen could be benign or malignant and may arise from various organs like the stomach, intestines, or pancreas. Symptoms include swelling, pain, and digestive issues. Diagnostic imaging and biopsies are used to determine the nature of the tumor, and treatment depends on the diagnosis.

The post-op sleeve diet is vital for healing and weight loss after sleeve gastrectomy. It begins with liquids, followed by pureed foods, and eventually includes solid foods. Protein intake is prioritized, and patients must avoid high-fat, high-sugar foods to prevent complications like nausea or dumping syndrome.

A pre-surgery diet prepares the body for bariatric surgery, typically focusing on reducing liver size and overall fat to make the procedure safer. This high-protein, low-carbohydrate diet often lasts for 1-2 weeks before surgery. Patients must follow a strict plan of liquids and protein shakes to shrink the liver and facilitate surgery.

The cost of stomach bypass surgery, another term for gastric bypass, can vary. In the UK, private clinics charge around £10,000 to £15,000. The NHS may offer this procedure for patients who meet specific eligibility criteria based on their BMI and health conditions.